This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Washington University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Amy Strickland: Innovator in Neurolytic Agents
Introduction
Amy Strickland is a prominent inventor based in St. Louis, MO (US). She has made significant contributions to the field of neurolytic agents, showcasing her expertise and innovative spirit. With a focus on advancing medical science, her work has the potential to impact various therapeutic applications.
Latest Patents
Amy Strickland holds 1 patent for her invention titled "Neurolytic agents and methods of using and identifying same." This patent includes the provision of a SARM1 activating agent or prodrug thereof, along with methods for utilizing these agents effectively. Her research is at the forefront of developing new therapeutic strategies.
Career Highlights
Strickland is affiliated with Washington University, where she continues to push the boundaries of scientific research. Her work is characterized by a commitment to innovation and a desire to improve patient outcomes through her discoveries.
Collaborations
Throughout her career, Amy has collaborated with notable colleagues, including Jeffrey D. Milbrandt and Aaron Diantonio. These partnerships have enriched her research and contributed to the advancement of her projects.
Conclusion
Amy Strickland exemplifies the spirit of innovation in the field of neurolytic agents. Her contributions are paving the way for future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile